Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance - Top-Institutions - MDSpire

Exploring the Relationship Between Inflammation, Kinase Signaling, and Treatment Resistance in Inflammatory Myofibroblastic Tumors

  • By

  • Sara Maiti

  • Archana Rose Reji

  • Swathi Senthil

  • Rakshana R.

  • Rekha Solairaju

  • Rehana Kunjumon

  • Payel Ghosh

  • Syama H.P.

  • Pritam Sadhukhan

  • Arkajyoti Dutta

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Sarcoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Sarcoma

Original Source(s)

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance

  • by Sara Maiti, Archana Rose Reji, Swathi Senthil, Rakshana R., Rekha Solairaju, Rehana Kunjumon, Payel Ghosh, Syama H.P., Pritam Sadhukhan, Arkajyoti Dutta

  • July 21, 2026

Related Content

Editorial: Navigating the landscape of IDH-mutant gliomas: advances in diagnosis, therapeutic management, and long-term monitoring

Circadian rhythms in the tumor microenvironment: spatiotemporal immune regulation and chronotherapeutic opportunities

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development